Xiaoli Yang1, Qinyong Ye2, Guofa Cai1, Yingqing Wang2, Guoen Cai2. 1. School of Information EngineeringGuangdong University of Technology Guangzhou 510000 China. 2. Department of NeurologyFujian Medical University Union Hospital Fuzhou 350001 China.
Abstract
OBJECTIVE: To develop an objective and efficient method to automatically identify Parkinson's disease (PD) and healthy control (HC). METHODS: We design a novel model based on residual network (ResNet) architecture, named PD-ResNet, to learn the gait differences between PD and HC and between PD with different severity levels. Specifically, a polynomial elevated dimensions technique is applied to increase the dimensions of the input gait features; then, the processed data is transformed into a 3-dimensional picture as the input of PD-ResNet. The synthetic minority over-sampling technique (SMOTE), data augmentation, and early stopping technologies are adopted to improve the generalization ability. To further enhance the classification performance, a new loss function, named improved focal loss function, is developed to focus on the train of PD-ResNet on the hard samples and to discard the abnormal samples. RESULTS: The experiments on the clinical gait dataset show that our proposed model achieves excellent performance with an accuracy of 95.51%, a precision of 94.44%, a recall of 96.59%, a specificity of 94.44%, and an F1-score of 95.50%. Moreover, the accuracy, precision, recall, specificity, and F1-score for the classification of early PD and HC are 92.03%, 94.20%, 90.28%, 93.94%, and 92.20%, respectively. Furthermore, the accuracy, precision, recall, specificity, and F1-score for the classification of PD with different severity levels are 92.03%, 94.29%, 90.41%, 93.85%, and 92.31%, respectively. CONCLUSION: Our proposed method shows better performance than the traditional machine learning and deep learning methods. CLINICAL IMPACT: The experimental results show that the proposed method is clinically meaningful for the objective assessment of gait motor impairment for PD patients.
OBJECTIVE: To develop an objective and efficient method to automatically identify Parkinson's disease (PD) and healthy control (HC). METHODS: We design a novel model based on residual network (ResNet) architecture, named PD-ResNet, to learn the gait differences between PD and HC and between PD with different severity levels. Specifically, a polynomial elevated dimensions technique is applied to increase the dimensions of the input gait features; then, the processed data is transformed into a 3-dimensional picture as the input of PD-ResNet. The synthetic minority over-sampling technique (SMOTE), data augmentation, and early stopping technologies are adopted to improve the generalization ability. To further enhance the classification performance, a new loss function, named improved focal loss function, is developed to focus on the train of PD-ResNet on the hard samples and to discard the abnormal samples. RESULTS: The experiments on the clinical gait dataset show that our proposed model achieves excellent performance with an accuracy of 95.51%, a precision of 94.44%, a recall of 96.59%, a specificity of 94.44%, and an F1-score of 95.50%. Moreover, the accuracy, precision, recall, specificity, and F1-score for the classification of early PD and HC are 92.03%, 94.20%, 90.28%, 93.94%, and 92.20%, respectively. Furthermore, the accuracy, precision, recall, specificity, and F1-score for the classification of PD with different severity levels are 92.03%, 94.29%, 90.41%, 93.85%, and 92.31%, respectively. CONCLUSION: Our proposed method shows better performance than the traditional machine learning and deep learning methods. CLINICAL IMPACT: The experimental results show that the proposed method is clinically meaningful for the objective assessment of gait motor impairment for PD patients.
Entities:
Keywords:
Gait motor disorder; PD-ResNet; Parkinson’s disease (PD); improved focal loss function
Authors: Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Carl Counsell; Nir Giladi; Robert G Holloway; Charity G Moore; Gregor K Wenning; Melvin D Yahr; Lisa Seidl Journal: Mov Disord Date: 2004-09 Impact factor: 10.338
Authors: Ronald B Postuma; Daniela Berg; Matthew Stern; Werner Poewe; C Warren Olanow; Wolfgang Oertel; José Obeso; Kenneth Marek; Irene Litvan; Anthony E Lang; Glenda Halliday; Christopher G Goetz; Thomas Gasser; Bruno Dubois; Piu Chan; Bastiaan R Bloem; Charles H Adler; Günther Deuschl Journal: Mov Disord Date: 2015-10 Impact factor: 10.338
Authors: David Ahmedt-Aristizabal; Mohammad Ali Armin; Simon Denman; Clinton Fookes; Lars Petersson Journal: Sensors (Basel) Date: 2021-07-12 Impact factor: 3.576
Authors: A Samà; C Pérez-López; D Rodríguez-Martín; A Català; J M Moreno-Aróstegui; J Cabestany; E de Mingo; A Rodríguez-Molinero Journal: Comput Biol Med Date: 2017-03-23 Impact factor: 4.589
Authors: Anat Mirelman; Mor Ben Or Frank; Michal Melamed; Lena Granovsky; Alice Nieuwboer; Lynn Rochester; Silvia Del Din; Laura Avanzino; Elisa Pelosin; Bastiaan R Bloem; Ugo Della Croce; Andrea Cereatti; Paolo Bonato; Richard Camicioli; Theresa Ellis; Jamie L Hamilton; Chris J Hass; Quincy J Almeida; Maidan Inbal; Avner Thaler; Julia Shirvan; Jesse M Cedarbaum; Nir Giladi; Jeffrey M Hausdorff Journal: Mov Disord Date: 2021-05-06 Impact factor: 10.338
Authors: Marc Bächlin; Meir Plotnik; Daniel Roggen; Inbal Maidan; Jeffrey M Hausdorff; Nir Giladi; Gerhard Tröster Journal: IEEE Trans Inf Technol Biomed Date: 2009-11-10
Authors: Catarina Godinho; Josefa Domingos; Guilherme Cunha; Ana T Santos; Ricardo M Fernandes; Daisy Abreu; Nilza Gonçalves; Helen Matthews; Tom Isaacs; Joy Duffen; Ahmed Al-Jawad; Frank Larsen; Artur Serrano; Peter Weber; Andrea Thoms; Stefan Sollinger; Holm Graessner; Walter Maetzler; Joaquim J Ferreira Journal: J Neuroeng Rehabil Date: 2016-03-12 Impact factor: 4.262